(Annals of Thoracic Surgery[TA])
41,214 results
  • In Memoriam: L. Penfield Faber, MD (October 30, 1931-June 32026, ). [Journal Article]
    Ann Thorac Surg. 2026 Aug 06. [Online ahead of print]Seder CW, Liptay MJAT
  • Leroy Penfield Faber, MD recently passed at the age of 97 years old. He was a master educator, an early proponent of multidisciplinary cancer care, and instrumental in developing flexile bronchoscopy, stapled bronchial closure, and segmental lung resections for cancer. Dr. Faber leaves behind a specialty that bears his imprint at many levels: in its culture, its standards, its leadership, and in …
  • A NEW ERA FOR THE SURGICAL TREATMENT OF ATRIAL FIBRILLATION: EVOLVING SURGICAL TECHNIQUES AND CLINICAL CONSIDERATIONS. [Review]
    Ann Thorac Surg. 2026 Aug 06. [Online ahead of print]Kiankhooy A, Eqbal A, … Ingason AAT
  • The fundamentals of effective surgical treatment for atrial fibrillation were established over 30 years ago with the development of the Cox-Maze operation. Restoration of atrioventricular synchrony, reduction of thromboembolic stroke risk, and symptom relief have always been the primary goals of therapy. Over time, surgical techniques and clinical considerations have significantly evolved, reachi…
  • Dropout after Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer in the Veterans Health Administration. [Journal Article]
    Ann Thorac Surg. 2026 Aug 05. [Online ahead of print]Brandt WS, Eaton DB, … Puri VAT
  • CONCLUSIONS: In our nationally representative cohort, patients undergoing chemoimmunotherapy with intent for surgical resection had favorable intermediate-term survival. however, nearly one-third of patients did not undergo surgery, most commonly due to disease progression. These findings highlight the need to better identify patients who do not progress to resection and define management strategies for these patients.